ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,031Medicare Part D Prescriptions Filled, Including Refills

Rank: 332 out of 1456

$535K Total Retail Price of All Prescriptions

Rank: 407 out of 1456

304 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 304 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,742 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 469 374 1 2
LEVOTHYROXINE SODIUM 436 380 2 4
LISINOPRIL 396 294 3 3
AMLODIPINE BESYLATE 340 238 4 1
POTASSIUM CHLORIDE 304 233 5 15
PRAVASTATIN SODIUM 292 223 6 9
OMEPRAZOLE 290 249 7 5
HYDROCODONE-ACETAMINOPHEN 270 221 S3 8 6
GABAPENTIN 249 156 9 13
METOPROLOL SUCCINATE 200 161 10 19
METFORMIN HCL 191 140 11 8
FUROSEMIDE 186 167 12 7
METOPROLOL TARTRATE 167 158 13 12
NEXIUM 161 80 14 23
CARVEDILOL 158 122 15 20
SPIRONOLACTONE 157 127 16 73
HYDROCHLOROTHIAZIDE 140 126 17 10
WARFARIN SODIUM 133 107 18 21
MELOXICAM 124 101 19 30
CLOPIDOGREL 122 105 20 32
FLUTICASONE PROPIONATE 109 96 21 28
RANITIDINE HCL 104 87 22 27
SERTRALINE HCL 104 77 22 25
LOSARTAN POTASSIUM 104 90 22 16
TRAZODONE HCL 103 86 25 47
AMLODIPINE BESYLATE-BENAZEPRIL 101 78 26 61
ATORVASTATIN CALCIUM 97 86 27 11
DIOVAN 95 79 28 35
PLAVIX 91 84 29 46
ATENOLOL 80 57 30 18
TAMSULOSIN HCL 77 68 31 34
ALENDRONATE SODIUM 75 62 32 36
HYDRALAZINE HCL 73 56 33 48
BYSTOLIC 72 60 34 102
PAROXETINE HCL 71 63 35 67
CLONIDINE HCL 69 57 36 39
DILTIAZEM 24HR ER 66 62 37 126
LOVASTATIN 65 61 38 40
CITALOPRAM HBR 63 51 39 22
SPIRIVA 61 58 40 75
GLIPIZIDE 60 54 41 53
NITROGLYCERIN PATCH 60 57 41 178
DONEPEZIL HCL 58 55 43 29
TRAMADOL HCL 58 57 43 17
DIGOXIN 57 57 45 62
POLYETHYLENE GLYCOL 3350 56 47 46 85
HYDROXYZINE HCL 55 35 R 47 164
GLIPIZIDE XL 55 38 47 134
LOSARTAN-HYDROCHLOROTHIAZIDE 53 42 49 41
NIFEDIPINE ER 52 47 50 81
BENAZEPRIL HCL 52 49 50 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.